Ernst Heinen

2017

In 2017, Ernst Heinen earned a total compensation of $801.9K as Chief Development Officer at Aratana Therapeutics, a 17% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$83,200
Option Awards$199,142
Salary$315,000
Stock Awards$204,510
Total$801,852

Heinen received $315K in salary, accounting for 39% of the total pay in 2017.

Heinen also received $83.2K in non-equity incentive plan, $199.1K in option awards and $204.5K in stock awards.

Rankings

In 2017, Ernst Heinen's compensation ranked 10,011th out of 14,666 executives tracked by ExecPay. In other words, Heinen earned more than 31.7% of executives.

ClassificationRankingPercentile
All
10,011
out of 14,666
32nd
Division
Manufacturing
3,872
out of 5,772
33rd
Major group
Chemicals And Allied Products
1,354
out of 2,075
35th
Industry group
Drugs
1,098
out of 1,731
37th
Industry
Pharmaceutical Preparations
859
out of 1,333
36th
Source: SEC filing on June 8, 2018.

Heinen's colleagues

We found three more compensation records of executives who worked with Ernst Heinen at Aratana Therapeutics in 2017.

2017

Steven Peter

Aratana Therapeutics

Chief Executive Officer

2017

Craig Tooman

Aratana Therapeutics

Chief Financial Officer

2017

Brent Standridge

Aratana Therapeutics

Chief Operating Officer

You may also like